UK medicines regulator specs out independent future

Breakups can be messy, but 18 months after the UK formally left the European Union, the newly-empowered Medicines and Healthcare products Regulatory Agency (MHRA) is determined to stay strong.

Transitioning from the old system to the new, the British medicines regulator has a lot of work to do, as well as significant opportunities to improve access to medicines.

Speaking at the Westminster Health Forum in London, chief partnerships officer Glenn Wells said the MHRA has an ambition to be a “World leading regulator,” focused on patient safety, adding the agency “now has strategies in place” to make that a reality.